Comments
U.S. ponders heart safety trials for obesity drugs
27.03.2012. | WASHINGTON (Reuters) - U.S. health regulators are asking for advice on whether, and when, heart safety studies should be required for new obesity drugs, possibly adding a new hurdle on their path to approval....
